Table of Content

1 INTRODUCTION
1.1 Study Assumptions? and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Industry Attractiveness - Porter’s Five Force Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Intensity of Competitive Rivalry
4.2.5 Threat of Substitute Products
4.3 Market Drivers??
4.3.1 Increasing Chronic Diseases and Growing Aging Population
4.3.2 Rising Healthcare Expenditure
4.4 Market Restraints?
4.4.1 Lack of Adequate Information and Communication Technology Infrastructure in Rural Areas?
4.5 Assessment of Impact of Covid-19 on the Industry


5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 COPD Telemonitoring System
5.1.2 Glucose Level Telemonitoring System
5.1.3 Cardiac Telemonitoring System
5.1.4 Blood Pressure Telemonitoring System
5.1.5 Other Product Types
5.2 Geography
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 Latin America
5.2.5 Middle East and Africa


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 GE Healthcare Systems (General Electric Company)
6.1.3 Care Innovations LLC?
6.1.4 Koninklijke Philips NV
6.1.5 Aerotel Medical Systems Ltd?
6.1.6 Boston Scientific Corporation?
6.1.7 Resideo Technologies Inc.?
6.1.8 Sparrow Health System?
6.1.9 InfoBionic Inc.?
6.1.10 AMD Global Telemedicine Inc.?
6.1.11 SHL Telemedicine?
6.1.12 Omron Corporation?
6.1.13 Nihon Kohden Corporation


7 INVESTMENT ANALYSIS


8 MARKET OPPORTUNITIES AND FUTURE TRENDS